| Authors: |
Hasanali ZS; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Garfall AL; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Burzenski L; Jackson Laboratories, Bar Harbor, Maine, USA., Shultz LD; Jackson Laboratories, Bar Harbor, Maine, USA., Tang Y; Center for Cellular Immunotherapies., Kadu S; Center for Cellular Immunotherapies., Sheppard NC; Center for Cellular Immunotherapies.; Department of Pathology and Laboratory Medicine, and., Liu W; Center for Cellular Immunotherapies., Dopkin D; Stem Cell and Xenograft Core Facility, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Vogl DT; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Cohen AD; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Waxman AJ; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Susanibar-Adaniya SP; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Carroll M; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Stem Cell and Xenograft Core Facility, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Stadtmauer EA; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Allman D; Department of Pathology and Laboratory Medicine, and. |
